EUVIMEDEUVIMED entdecken
Crossref

BioDKG–DDI: predicting drug–drug interactions based on drug knowledge graph fusing biochemical information

Zhong-Hao Ren iD, Chang-Qing Yu, Li-Ping Li, Zhu-Hong You, Yong-Jian Guan, Xin-Fei Wang, Jie Pan

Briefings in Functional Genomics · 21.05.2022 · 21 (3) · 216-229

DOI: 10.1093/bfgp/elac004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Functional Genomics, online erschienen am 03.04.2022. Verfasst von Zhong-Hao Ren und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neural Networks, Computer, Pattern Recognition, Automated. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The way of co-administration of drugs is a sensible strategy for treating complex diseases efficiently. Because of existing massive unknown interactions among drugs, predicting potential adverse drug–drug interactions (DDIs) accurately is promotive to prevent unanticipated interactions, which may cause significant harm to patients. Currently, numerous computational studies are focusing on potential DDIs prediction on account of traditional experiments in wet lab being time-consuming, labor-consuming, costly and inaccurate. These approaches performed well; however, many approaches did not consider multi-scale features and have the limitation that they cannot predict interactions among novel drugs. In this paper, we proposed a model of BioDKG–DDI, which integrates multi-feature with biochemical information to predict potential DDIs through an attention machine with superior performance. Molecular structure features, representation of drug global association using drug knowledge graph (DKG) and drug functional similarity features are fused by attention machine and predicted through deep neural network. A novel negative selecting method is proposed to certify the robustness and stability of our method. Then, three datasets with different sizes are used to test BioDKG–DDI. Furthermore, the comparison experiments and case studies can demonstrate the reliability of our method. Upon our finding, BioDKG–DDI is a robust, yet simple method and can be used as a benefic supplement to the experimental process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Networks, ComputerPattern Recognition, AutomatedDrug InteractionsHumansPharmaceutical PreparationsReproducibility of Results

Stichwörter der Autor:innen

DDIs drug–drug interactionsdeep learningdrug knowledge graphmulti-feature integrationrepresentation attention

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

ORCID-Profile: Zhong-Hao Ren

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ren, Z. H., Yu, C. Q., Li, L. P., You, Z. H., Guan, Y. J., Wang, X. F., & Pan, J. (2022). BioDKG–DDI: predicting drug–drug interactions based on drug knowledge graph fusing biochemical information. Briefings in Functional Genomics, 21(3), 216-229. https://doi.org/10.1093/bfgp/elac004

Vancouver

Ren ZH, Yu CQ, Li LP, You ZH, Guan YJ, Wang XF, et al. BioDKG–DDI: predicting drug–drug interactions based on drug knowledge graph fusing biochemical information. Briefings in Functional Genomics. 2022;21(3):216-229. doi:10.1093/bfgp/elac004

BibTeX
@article{Ren2022,
  author = {Ren, Zhong-Hao and Yu, Chang-Qing and Li, Li-Ping and You, Zhu-Hong and Guan, Yong-Jian and Wang, Xin-Fei and Pan, Jie},
  title = {BioDKG–DDI: predicting drug–drug interactions based on drug knowledge graph fusing biochemical information},
  journal = {Briefings in Functional Genomics},
  year = {2022},
  volume = {21},
  number = {3},
  pages = {216--229},
  doi = {10.1093/bfgp/elac004}
}
Kostenlos starten →